# A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations

> **NCT06019481** · — · WITHDRAWN · sponsor: **Regeneron Pharmaceuticals**

## Conditions studied

- Congenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF)
- Biallelic Mutations in the Gap Junction Beta 2 (GJB2) Gene
- Digenic Mutations in GJB2/Gap Junction Beta 6 (GJB6) Genes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06019481
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-06-30
- **Primary completion:** 2030-06-30
- **Final completion:** 2030-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06019481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06019481, "A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06019481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*